14Indexed trials
mesh condition
Fragile X Syndrome
Intelligence
Fragile X Syndrome intelligence: 14 indexed trials, 3 recruiting studies, 10 sponsors across 4 countries.
3Recruiting
10Sponsors
4Countries
Leading sponsors
Seaside Therapeutics, Inc.30 recruiting
Université de Sherbrooke21 recruiting
Tetra Discovery Partners21 recruiting
Nova Mentis Life Science Corp10 recruiting
ProgenaBiome10 recruiting
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud10 recruiting
Connecta Therapeutics, S.L.11 recruiting
University Hospital, Tours10 recruiting
University of Alberta10 recruiting
Institute for Neurodegenerative Disorders10 recruiting
Geographic activity
United States8trials
Canada2trials
Spain2trials
France1trials
Leading interventions
STX2092trials
Biological samples1trials
CBD Oral Solution (eCBD system Target)1trials
CTH1201trials
CTH120 placebo hard capsules1trials
Lovastatin, then Minocycline/Lovastatin1trials
MRI1trials
Metformin1trials
Minocycline, then Minocycline/Lovastatin1trials
Placebo Medication1trials
Vitamin C 10mg/Kg Vitamin E 10 mg/Kg1trials
Zatolmilast/ BPN147701trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.